Blood cell analysis based on time-domain stretched ultrafast optical imaging technique

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000039031

Enrollment

Unknown

Registered

2020-10-14

Start date

2020-07-14

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic tumor

Interventions

Gold Standard:Bone marrow examination + flow + biopsy + gene + chromosome +FISH??????

Index test:Cell imaging

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Subjects who meet the following criteria can be enrolled in this project: 1. Patients aged 18-60 years old; 2. Patients diagnosed with hematological tumor; 3. Patients with ECoG behavioral status score of 0-2; 4. Patients with normal liver and kidney function: blood bilirubin 50%; lung function: indoor oxygen saturation >= 95%;

Exclusion criteria

Exclusion criteria: Patients with severe reduction in myelodysplasia and absolute reduction in bone marrow cell count.

Design outcomes

Primary

Measure	Time frame
blood count;Unlabeled cell imaging;	—

Countries

China

Contacts

Public ContactFuling Zhou

ZhongNan Hospital of Wuhan University

zhoufuling@whu.edu.cn+86 18986265580

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026